Clicky

Petros Pharmaceuticals, Inc.(PTPI)

Description: Petros is committed to becoming the world's leading men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to ED, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease (acute and chronic), hormone health and substance use disorders.


Keywords: Medicine Disease Disorders Dysfunction Chronic Condition Sexual Health Men's Health Petros Substance Use Disorder Peyronie's Disease Psychosocial

Home Page: www.petrospharma.com

PTPI Technical Analysis

1185 Avenue of the Americas
New York, NY 10036
United States
Phone: 973 242 0005


Officers

Name Title
Mr. John D. Shulman Exec. Chairman
Mr. Fady Boctor M.B.A. Principal Exec. Officer, Pres & Chief Commercial Officer
Mr. Mitchell S. Arnold M.B.A. VP of Fin. & Chief Accounting Officer
Mr. Robert Weinstein Interim Chief Financial Officer
Mr. Keith F. Lavan Advisor

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.2331
Price-to-Sales TTM: 1.0146
IPO Date: 2020-12-02
Fiscal Year End: December
Full Time Employees: 24
Back to stocks